X

Register to download the report. Already a member?

Download PDF

Click Here for $250 / 6 months

Click Here for $450 / year

BioInvent receives clinical milestone in partner program

15.08.2013 / Energyboardroom

BioInvent International OMXSBINV today announces that it will receive a milestone payment in connection with a partners start of a phase I clinical study using a nCoDeRÂ antibody. BioInvents pipeline of external drug programm…

view original story on Oil & Gas Journal
LATEST ISSUE

DOWNLOAD

Most Read